• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

AHA ‘Respectfully Urges’ CMS to Begin ICD-10 Testing by January 2014

by Fred Pennic 11/27/2013 2 Comments

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

The American Hospital Association (AHA) has sent a letter encouraging CMS to expedite their ICD-10 testing plans to ensure testing begins no later than January 2014 and is made available to all hospitals. Despite CMS offering extensive ICD-10 educational opportunities, the AHA states that “extensive, end-to-end testing by Medicare contractors and state Medicaid agencies of both the electronic transaction and the adjudication of the claim will be needed to ensure a smooth transition from ICD-9 to ICD-10.”

In the letter addressed to CMS Deputy Administrator and Director, Jonathan Plum, states, “testing is not only essential to ensuring that the transition to ICD-10 goes as smoothly as possible, it is a legal requirement under Section 1104 of the Patient Protection and Affordable Care Act (ACA). Specifically, the ACA requires all health plans (including Medicare and Medicaid) to certify that they are in compliance with all HIPAA transaction standards and operating rules, including ICD-10.

The ACA goes on to state that a health plan “shall not be certified as being in compliance with such standards, unless the health plan … provides documentation showing that the plan has completed end-to-end testing for such transactions with their partners, such as hospitals and physicians,” said Linda Fishman, AHA senior vice president of public policy analysis and development.

Importance of Early ICD-10 Testing

According to the letter, all ICD-10 testing should be completed by the end of June 2014 for:

  • providers, payers and clearinghouses to resolve any issues discovered during ICD-10 testing
  • complete training well in advance of the Oct. 1, 2014 transition date

Essential Components of ICD-10 Testing

Most hospitals are already targeting January through June 2014 to conduct external ICD-10 testing with their partners. The AHA also identified two essential components for successful ICD-10 testing:

  • Testing connectivity and the transaction exchange for a claim containing ICD-10 codes.
  • Testing the provider’s and payer’s ability to correctly handle the ICD-10 content as part of the claims adjudication process.

Additionally, hospitals should be provided with clear instructions on how to register for testing including an established “go-live” date for ICD-10 testing for all Medicare contractors.

In 2011, the U.S. Department of Health and Human Services (HHS) estimated that the overall cost of ICD-10 transition would be $1.64 billion. This estimate includes:

  • $357 million for staff training
  • $572 million for losses in productivity
  • $713 million for system changes
  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |